Why Region Matters Before You Buy

The same extract can be a freely-sold supplement ingredient in one market and a tightly-controlled or claim-restricted one in another. Getting this wrong is expensive: a shipment can clear customs and still be unsaleable because the label claim isn't permitted, or be detained because contaminant documentation doesn't meet the importing country's standard. Decide the destination market first, then specify accordingly.

European Union

In the EU, botanical ingredients in food supplements sit under national lists and the harmonised framework around health claims. Health claims must be from the authorised register; general botanical "on-hold" claims and structure-function wording are handled cautiously, and unauthorised disease or treatment claims are not permitted. Where an ingredient or a specific preparation lacks a significant history of consumption in the EU before May 1997, the Novel Food question arises and must be checked for your exact preparation. Contaminant limits (heavy metals, contaminants in food) follow EU food law. Practically: keep claims conservative, confirm the novel-food status of your specific extract, and hold full contaminant data.

United States

In the US, Boswellia serrata extract is marketed as a dietary supplement ingredient under DSHEA. Products must meet cGMP (21 CFR 111), and labels may carry structure-function claims (with the required FDA disclaimer) but not disease claims. Depending on marketing history, a New Dietary Ingredient (NDI) notification may be relevant for certain novel preparations. Identity, potency and contaminant testing must support the label. Practically: structure-function claims only, robust cGMP documentation, and a CoA that backs every label figure.

India

In India, Boswellia (Shallaki / Salai guggul) has deep Ayurvedic use and is regulated through the food/nutraceutical framework under FSSAI as well as AYUSH pathways for traditional formulations. Specifications, permitted use levels and contaminant limits follow the applicable FSSAI regulations. As the country of origin and manufacture, exporters here document botanical identity, assay and safety data to support both domestic sale and export.

Market-Access Snapshot

MarketFrameworkClaims PostureWatch-Out
EUFood supplement / health-claims regimeAuthorised claims only; conservativeNovel Food status of the specific preparation
USDietary supplement (DSHEA), cGMP 21 CFR 111Structure-function with disclaimer; no disease claimsPossible NDI notification for novel preparations
IndiaFSSAI nutraceutical / AYUSHPer FSSAI & traditional-use pathwaysUse-level and contaminant limits per regulation

Contaminant & Safety Documentation

Across all three markets, the recurring requirement is a complete contaminant and safety dossier on the lot you ship:

Bottom line: the extract's regulatory acceptability rests as much on its documentation as its chemistry. A method-stated assay plus a full contaminant panel is what turns a compliant product into a clearable shipment.

For what a complete document set looks like, see the buyer's guide, and for confirming species identity before you commit, see species & adulteration.